Showing results (271-280 of 607) with videos related to

Sort By:
Pageof 61
The Journal of Biological Chemistry|October 6, 2009
Fenofibrate simultaneously induces hepatic fatty acid oxidation, synthesis, and elongation in miceMaaike H Oosterveer, Aldo Grefhorst, Theo H van Dijk, et al.
The Journal of Biological Chemistry|October 16, 2002
Transcriptional regulation of human Rev-erbalpha gene expression by the orphan nuclear receptor retinoic acid-related orphan receptor alphaEric Raspè, Gisèle Mautino, Caroline Duval, et al.
International Journal of Cardiology|May 24, 2015
Atherosclerosis: Recent trials, new targets and future directionsRicardo Ladeiras-Lopes, Stefan Agewall, Ahmed Tawakol, et al.
The Journal of Biological Chemistry|December 23, 2003
Hepatic de novo synthesis of glucose 6-phosphate is not affected in peroxisome proliferator-activated receptor alpha-deficient mice but is preferentially directed toward hepatic glycogen stores after a short term fastRobert H J Bandsma, Theo H Van Dijk, Anke ter Harmsel At, et al.
Diabetes Care|May 30, 2013
Dual peroxisome proliferator-activated receptor α/δ agonist GFT505 improves hepatic and peripheral insulin sensitivity in abdominally obese subjectsBertrand Cariou, Rémy Hanf, Stéphanie Lambert-Porcheron, et al.
The Journal of Biological Chemistry|November 30, 2013
Peroxisome proliferator-activated receptor γ regulates genes involved in insulin/insulin-like growth factor signaling and lipid metabolism during adipogenesis through functionally distinct enhancer classesFrédérik Oger, Julie Dubois-Chevalier, Céline Gheeraert, et al.
Metabolic Brain Disease|October 17, 2017
Risperidone-induced metabolic dysfunction is attenuated by Curcuma longa extract administration in miceFlorent Auger, Françoise Martin, Olivier Pétrault, et al.
Gastroenterology|August 2, 2003
Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expressionThierry Claudel, Yusuke Inoue, Olivier Barbier, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 11, 2008
Rimonabant, a selective cannabinoid CB1 receptor antagonist, inhibits atherosclerosis in LDL receptor-deficient miceFrédérique Dol-Gleizes, Réjane Paumelle, Virgile Visentin, et al.
Acta Diabetologica|June 23, 2009
Is the current therapeutic armamentarium in diabetes enough to control the epidemic and its consequences? What are the current shortcomings?Dario Giugliano, Eberhard Standl, Tina Vilsbøll, et al.
Pageof 61